-
Acer Therapeutics to Participate in Upcoming Investor Conferences
-
Acer Therapeutics Announces Closing of Underwritten Public Offering
-
Acer Therapeutics (ACER) Prices 2.22M Share Common Offering at $18/Sh
-
Acer Therapeutics Announces Pricing of Underwritten Public Offering
-
Roth Capital Starts Acer Therapeutics (ACER) at Buy

